ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2177

Characterization of Crevicular Fluid Microbiota in Primary Sjögren’s Syndrome

Gabriela Hernandez-Molina1, Alberto Lopez-Reyes2, Carlos Hernandez-Hernandez3, Vanessa Ruiz3, Amaya Llorente-Chavez4, Vanessa Saavedra-González4, Luis llorente4 and Gabriela Martínez-Nava2, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Laboratorio de Gerociencias, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico, 3Servicio Dental. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 4Departamento de Inmunología y Reumatología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Meeting: ACR Convergence 2023

Keywords: microbiome, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2177–2194) Sjögren’s Syndrome – Basic & Clinical Science Poster II

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To describe the taxonomic composition of the microbiota in the crevicular fluid of patients with primary Sjögren’s syndrome (PSS), and to assess their association with parotid gland enlargement, periodontal disease, oral quality of life, and anti-Ro/SSA and anti-La/SSB antibodies.

Methods: We included 48 PSS patients according to the ACR/EULAR criteria. We excluded patients with concomitant connective tissue disease, diabetes mellitus, active neoplasia, antibiotic use in the two weeks before the study, or with current active infection. A single rheumatologist registered the following variables: demographics, disease duration, oral/ocular sicca symptoms, parotid enlargement and serology. We evaluated the non-stimulated whole salivary flow (NSWSF). Patients rated the ESSPRI and the Xerostomia-related Quality of Life Scale (XeQoLS). Two experienced periodontists systematically examined six sites per tooth of each patient, to determine the presence of periodontal disease. Crevicular fluid was collected from 6 teeth with the greatest periodontal pocket depth using filter paper (sterile paper points). Samples were immediately frozen at -86 °C until processing. We also included 17 control subjects from the same hospital’s Dentistry department matched by gender and age (±5 years). Bacterial DNA was extracted from the crevicular fluid sample using a commercial kit. 16SrRNA V3-V4 region was sequenced using reversible adaptor technology. Sequences were pre-processed and analyzed with QIIME2 and phyloseq software programs. Functionality profiles were predicted using the Tax4Fun2 package.

Results: Most patients were women, the mean age was 52.4 years and the median disease duration was 9.3 years. We found that the microbiota of PSS patients contained more bacteria of the genera Prevotella, Streptococcus, Veillonella, Fusobacterium, and Leptotrichia genera and fewer bacteria of the genus Selenomonas than that of healthy subjects. We also found significant differences in microbiota taxonomy between patients with anti-Ro or anti-La positive antibodies, parotid gland enlargement ( Figure 1) , and periodontal disease severity ( Figure 2) . We found no correlation between microbiota and NSWSF, and oral quality of life. The predicted functional profile showed that the microbiota of PSS patients contained more genes encoding for accessory secretory proteins than healthy controls.

Conclusion: The composition of the crevicular fluid microbiota of PSS patients and healthy subjects differed significantly. Differences were found among patients with parotid gland enlargement as well as anti-Ro and anti-La antibody positivity, suggesting that autoimmunity per se may play an important role in the composition of the oral microbiota in PSS.

Supporting image 1

Figure 1 . Alfa diversity indexes stratified by the presence of (A) anti-Ro/SSA, (B) anti-La/SSB, and (C) parotid enlargement; and beta diversity compared between the presence of (D) anti-Ro/SSA , (E) anti-La/SSB, and (F) parotid enlargement.

Supporting image 2

Figure 2 ASVs that best describe the crevicular fluid microbiota of SS patients and healthy controls (A) SS patients negative to anti-Ro/SSA or anti-La/SSB and (B) SS patients with and without parotid enlargement

Supporting image 3

Figure 3 Bacteria genus ASVs whose relative abundance best describe the crevicular fluid microbiota of SS patients with mild and moderate or severe periodontal disease.


Disclosures: G. Hernandez-Molina: None; A. Lopez-Reyes: None; C. Hernandez-Hernandez: None; V. Ruiz: None; A. Llorente-Chavez: None; V. Saavedra-González: None; L. llorente: None; G. Martínez-Nava: None.

To cite this abstract in AMA style:

Hernandez-Molina G, Lopez-Reyes A, Hernandez-Hernandez C, Ruiz V, Llorente-Chavez A, Saavedra-González V, llorente L, Martínez-Nava G. Characterization of Crevicular Fluid Microbiota in Primary Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/characterization-of-crevicular-fluid-microbiota-in-primary-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-crevicular-fluid-microbiota-in-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology